Results 11 to 20 of about 224,806 (322)

Adhesins in Candida glabrata

open access: yesJournal of Fungi, 2018
The human fungal pathogen Candida glabrata is causing more and more problems in hospitals, as this species shows an intrinsic antifungal drug resistance or rapidly becomes resistant when challenged with antifungals. C.
B. Timmermans   +3 more
semanticscholar   +3 more sources

Genetic Manipulation of Candida glabrata

open access: yesCurrent Protocols
Candida glabrata (Nakaseomyces glabratus) is an opportunistic fungal pathogen that has become a significant concern in clinical settings due to its increasing resistance to antifungal treatments.
Jane Usher
semanticscholar   +3 more sources

S4.3b Candida glabrata-host interactions [PDF]

open access: hybridMedical Mycology, 2022
Abstract S4.3 Emergent species of the Candida genus, September 22, 2022, 10:30 AM - 12:00 PM Candida glabrata is among the most common pathogenic yeasts of humans. Yet, this fungus is phylogenetically, genetically, and phenotypically very different from other clinically relevant Candida species.
Bernhard Hube
openalex   +2 more sources

Expression Plasmids for Use inCandida glabrata [PDF]

open access: goldG3 Genes|Genomes|Genetics, 2013
AbstractWe describe a series of CEN/ARS episomal plasmids containing different Candida glabrata promoters, allowing for a range of constitutive or regulated expression of proteins in C. glabrata. The set of promoters includes three constitutive promoters (EGD2pr, HHT2pr, PDC1pr), two macrophage/phagocytosis-induced promoters (ACO2pr, LYS21pr), and one ...
Rebecca E. Zordan   +6 more
openalex   +5 more sources

In vitro antifungal potency of the moronecidin-like peptide against Candida albicans, Candida glabrata, and Candida tropicalis

open access: yesIranian Journal of Microbiology, 2023
Background and Objectives: The aim of this study was to investigate the in vitro antifungal potency of the moronecidin-like peptide against Candida albicans, Candida glabrata, and Candida tropicalis.
Nasrin Amirrajab   +4 more
doaj   +1 more source

Emergence of resistant Candida glabrata in Germany

open access: yesJAC-Antimicrobial Resistance, 2021
Background Candida glabrata is the second leading fungal pathogen causing candidaemia and invasive candidiasis in Europe. This yeast is recognized for its rapid ability to acquire antifungal drug resistance.
A. Aldejohann   +4 more
semanticscholar   +1 more source

Cell wall composition and biofilm formation of azoles-susceptible and -resistant Candida glabrata strains [PDF]

open access: yes, 2011
In the present study, three strains of Candida glabrata have been investigated to shed light on the mechanisms involved in azole resistance during adherence and biofilm formation.
Vitali, Alberto   +6 more
core   +5 more sources

Multiple Intravitreal Liposomal Amphotericin B for a Case of Candida glabrata Endophthalmitis

open access: yesCase Reports in Ophthalmology, 2021
We report a case of Candida glabrata endophthalmitis which was effectively treated by intravitreal liposomal amphotericin B (L-AMB) injection. A 72-year-old man was referred to our department for positive blood culture of Candida glabrata.
Daiki Sakai   +2 more
doaj   +1 more source

Gross karyotypic and phenotypic alterations among different progenies of the candida glabrata cbs138/atcc2001 reference strain [PDF]

open access: yes, 2012
Peer reviewedPublisher ...
Bader, Oliver   +8 more
core   +10 more sources

Candida glabrata, Friend and Foe [PDF]

open access: yesJournal of Fungi, 2015
Candida glabrata is mostly good, but, at times, it is an opportunistic pathogen. Previously known as Torulopsis glabrata, it enjoyed a good reputation and was even present in starter cultures. Its haploid genome and lack of mating made it an attractive challenge for yeast genetics studies.
Tam, Phyllix   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy